News

Investors Encouraged to Join Altimmune Class Action Suit

Investors Encouraged to Join Altimmune Class Action Suit

Understanding the Class Action Opportunity for Altimmune Investors

For investors of Altimmune, Inc., a promising opportunity has emerged regarding a class action lawsuit prompted by allegations of securities fraud. This situation stems from contentious assertions made by the Company concerning its drug candidate, Pemvidutide. Investors who acquired shares during the defined class period should take note and consider their options.

Potential Violations by Altimmune

Allegations against Altimmune assert violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5 as mandated by the U.S. Securities and Exchange Commission. These regulations were purportedly breached due to misleading statements related to the performance of Altimmune’s drug candidate.

Information on the Class Period

The class period, which is pivotal for those involved, spans from the day the questionable statements were made until it was revealed that the anticipated results from the Phase 2B MASH trial did not meet expectations. Specifically, the drug did not yield a statistically significant result in its primary endpoint, contradicting claims made by the Company.

Impact on Investors

When the truth surfaced, many investors experienced financial repercussions due to the misleading nature of the Company's public statements. Investors who believe they have incurred losses during this time are encouraged to come forward and make their voices heard before potential deadlines pass.

Ways to Get Involved

Shareholders who acquired Altimmune securities from August 10, 2023, to June 25, 2025, should reach out to the Schall Law Firm, which is leading the class action suit. Participating in this lawsuit could enable investors to recover their losses.

What the Schall Law Firm Offers

The Schall Law Firm specializes in representing investors globally, focusing on securities class action lawsuits. They offer a no-cost consultation for individuals wishing to discuss their legal rights and options. Investors can contact Brian Schall directly for a free discussion about their circumstances, ensuring they are well-informed and prepared to take necessary action.

Class Certification Status

It is important to note that the class action has not yet received certification. Thus, those who do not take action may remain absent class members and miss their chance to join the case. Timing is essential for those wishing to assert their rights and seek restitution.

The Substance Behind the Allegations

As represented in the complaint, Altimmune's optimistic reports regarding the efficacy of Pemvidutide were shown to be unfounded once the trial results were assessed. The disregard for the negative feedback from the Phase 2B MASH trial raised red flags, indicating possible negligence or misleading conduct in communicating with stakeholders.

Next Steps for Interested Investors

Investors interested in joining the class action or seeking additional information should reach out to the law firm promptly. Gaining insight into one's legal standing and potential claims can significantly influence the outcome for affected investors.

Frequently Asked Questions

1. What is a class action lawsuit?

A class action lawsuit allows a group of people with similar grievances against a company to file a single lawsuit. This can streamline the legal process and provide more effective representation.

2. How do I know if I am eligible to participate?

You may be eligible if you purchased Altimmune securities between the specified dates and suffered a loss. Consulting with legal counsel can clarify your eligibility.

3. What is the deadline to join the lawsuit?

It is imperative to reach out to the Schall Law Firm before the deadline of October 6, 2025, to ensure your involvement in this class action.

4. What are the implications if I do not join the lawsuit?

Failure to participate may mean missing the opportunity to recover any financial losses sustained during the relevant time period.

5. How can I contact the Schall Law Firm?

You can contact Brian Schall at the firm’s office or through their website to discuss your case and options for participation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 55

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 98

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 37

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 97

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 42

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 31

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 223

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 32

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 185

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights into Rathbones Group Plc's Position Disclosure

Updated Category News Views 171

Understanding Disclosure Requirements in Financial Markets In the world of finance and investments, transparency is paramount. Investors and market participants must be aware of regulations surrounding disclosure, especially when significant interest in relevant securities occurs. Here, we delve into key details surrounding a recent public disclosure by Rathbones Group...

Continue Reading
Atkore Inc. Announces Quarterly Cash Dividend for Shareholders

Updated Category News Views 139

Atkore Inc. Announces Cash Dividend for Shareholders Atkore Inc. (NYSE: ATKR), a prominent manufacturer known for its extensive electrical products, has informed its investors about the declaration of a quarterly cash dividend. This announcement signifies the company's ongoing commitment to providing value to its shareholders. The dividend is set at $0.32 per share of...

Continue Reading
Innovating Home Textiles: How CiCLO® is Changing Luxury Fabrics

Updated Category News Views 248

Innovative Technologies in Home Textiles An innovative fiber design blending renewable and biodegradable materials is advancing comfort, longevity, and responsible performance in premium home and hospitality textiles. At Heimtextil 2026, Intrinsic Advanced Materials will showcase a new generation of luxury textiles that embody sustainable practices, collaborating with...

Continue Reading
Vegan Food Industry Set for Huge Growth: USD 55.88 Billion by 2034

Updated Category News Views 271

Overview of the Vegan Food Market Growth The global vegan food market is anticipated to witness significant growth, increasing from USD 20.22 billion to an impressive USD 55.88 billion by 2034. This remarkable shift, with a compound annual growth rate (CAGR) of 10.7% from 2025 to 2034, reflects the rising consumer demand for plant-based options. Consumer Trends Driving...

Continue Reading
BAOS Stock Hits New Heights with Investor Enthusiasm

Updated Category News Views 190

BAOS Stock Surges to 52-Week High In a remarkable display of market confidence, Baosheng Media Group Holdings Limited (BAOS) has achieved a significant milestone by reaching a 52-week high of $7.33 per share. This surge demonstrates the strong backing from investors and the company's solid financial standing. Company Valuation and Financial Health The micro-cap company,...

Continue Reading